Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancer (FINEX pilot study)-Reference-Cited by-同舟云学术

Pilot study of the combination of sorafenib and fractionated irinotecan in pediatric relapse/refractory hepatic cancer (FINEX pilot study)

Published:2020-08-15 Issue:11 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Keino Dai¹^ORCID,Yokosuka Tomoko¹,Hirose Ayana¹,Sakurai Yukari¹,Nakamura Wataru¹,Fujita Sachio¹,Hayashi Akiko¹,Miyagawa Naoyuki¹,Iwasaki Fuminori¹,Hamanoue Satoshi¹,Yanagimachi Masakatsu¹,Shiomi Masae¹,Goto Shoko¹,Kitagawa Norihiko²,Tanaka Mio³,Nozawa Kumiko⁴,Tanaka Yukichi³,Goto Hiroaki¹

Affiliation:

1. Division of Hematology/Oncology Kanagawa Children's Medical Center Yokohama Japan

2. Division of Surgery Kanagawa Children's Medical Center Yokohama Japan

3. Division of Diagnostic Pathology Kanagawa Children's Medical Center Yokohama Japan

4. Division of Radiology Kanagawa Children's Medical Center Yokohama Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28655

Reference29 articles.